Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Future developments in the pharmacotherapy of lung disease.

Pharmaceutisch weekblad. Scientific edition

Van der Kuy A.
PMID: 1437503
Pharm Weekbl Sci. 1992 Aug 21;14(4):221-3. doi: 10.1007/BF01962543.

Future advances in the pharmacotherapy of lung disease will occur mainly in the treatment of asthma, and will include the development of new long-acting beta 2-agonists, long-acting parasympatholytics, phosphodiesterase inhibitors, corticosteroids with fewer systemic side-effects, and other antiinflammatory drugs....

Cite
Van der Kuy A. Future developments in the pharmacotherapy of lung disease. Pharm Weekbl Sci. 1992;14(4):221-3doi: 10.1007/BF01962543.
Van der Kuy, A. (1992). Future developments in the pharmacotherapy of lung disease. Pharmaceutisch weekblad. Scientific edition, 14(4), 221-3. https://doi.org/10.1007/BF01962543
Van der Kuy, A. "Future developments in the pharmacotherapy of lung disease." Pharmaceutisch weekblad. Scientific edition vol. 14,4 (1992): 221-3. doi: https://doi.org/10.1007/BF01962543
Van der Kuy A. Future developments in the pharmacotherapy of lung disease. Pharm Weekbl Sci. 1992 Aug 21;14(4):221-3. doi: 10.1007/BF01962543. PMID: 1437503.
Copy Download .nbib Format: NLM
Pharmacologic Agents for Chronic Diarrhea.

Intestinal research

Lee KJ.
PMID: 26576135
Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15.

Chronic diarrhea is usually associated with a number of non-infectious causes. When definitive treatment is unavailable, symptomatic drug therapy is indicated. Pharmacologic agents for chronic diarrhea include loperamide, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists, diosmectite, cholestyramine, probiotics, antispasmodics, rifaximin,...

Cite
Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015;13(4):306-12doi: 10.5217/ir.2015.13.4.306.
Lee, K. J. (2015). Pharmacologic Agents for Chronic Diarrhea. Intestinal research, 13(4), 306-12. https://doi.org/10.5217/ir.2015.13.4.306
Lee, Kwang Jae. "Pharmacologic Agents for Chronic Diarrhea." Intestinal research vol. 13,4 (2015): 306-12. doi: https://doi.org/10.5217/ir.2015.13.4.306
Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15. PMID: 26576135; PMCID: PMC4641856.
Copy Download .nbib Format: NLM
Engineered Microbes for Producing Anticholinergics.

Chembiochem : a European journal of chemical biology

Courdavault V, Cassereau J, Papon N.
PMID: 33215811
Chembiochem. 2021 Apr 16;22(8):1368-1370. doi: 10.1002/cbic.202000757. Epub 2020 Dec 17.

The tropane alkaloids (TAs) hyoscyamine and scopolamine function as acetylcholine receptor antagonists and are used clinically as parasympatholytics to treat neuromuscular disorders in humans. While TAs are synthesized in a small subset of plant families, these specialized metabolites are...

Cite
Courdavault V, Cassereau J, Papon N. Engineered Microbes for Producing Anticholinergics. Chembiochem. 2020;22(8):1368-1370doi: 10.1002/cbic.202000757.
Courdavault, V., Cassereau, J., & Papon, N. (2021). Engineered Microbes for Producing Anticholinergics. Chembiochem : a European journal of chemical biology, 22(8), 1368-1370. https://doi.org/10.1002/cbic.202000757
Courdavault, Vincent, et al. "Engineered Microbes for Producing Anticholinergics." Chembiochem : a European journal of chemical biology vol. 22,8 (2021): 1368-1370. doi: https://doi.org/10.1002/cbic.202000757
Courdavault V, Cassereau J, Papon N. Engineered Microbes for Producing Anticholinergics. Chembiochem. 2021 Apr 16;22(8):1368-1370. doi: 10.1002/cbic.202000757. Epub 2020 Dec 17. PMID: 33215811.
Copy Download .nbib Format: NLM
CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study.

Dementia and geriatric cognitive disorders extra

Puustinen J, Nurminen J, Vahlberg T, Lyles A, Isoaho R, Räihä I, Kivelä SL.
PMID: 22619661
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):57-68. doi: 10.1159/000336710. Epub 2012 Mar 16.

BACKGROUND/AIMS: Psychotropics and antiepileptics (AE) are medications commonly used among the aged with cognitive decline or dementia, although they may precipitate further cognitive decline. Our aim was to analyze the relationships between the use of (i) psychotropics (i.e. benzodiazepines...

Cite
Puustinen J, Nurminen J, Vahlberg T, et al. CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study. Dement Geriatr Cogn Dis Extra. 2012;2(1):57-68doi: 10.1159/000336710.
Puustinen, J., Nurminen, J., Vahlberg, T., Lyles, A., Isoaho, R., Räihä, I., & Kivelä, S. L. (2012). CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study. Dementia and geriatric cognitive disorders extra, 2(1), 57-68. https://doi.org/10.1159/000336710
Puustinen, Juha, et al. "CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study." Dementia and geriatric cognitive disorders extra vol. 2,1 (2012): 57-68. doi: https://doi.org/10.1159/000336710
Puustinen J, Nurminen J, Vahlberg T, Lyles A, Isoaho R, Räihä I, Kivelä SL. CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study. Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):57-68. doi: 10.1159/000336710. Epub 2012 Mar 16. PMID: 22619661; PMCID: PMC3350354.
Copy Download .nbib Format: NLM
Drug-Induced Ocular Hypertension and Angle-Closure Glaucoma.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Badhu BP, Bhattarai B, Sangraula HP.
PMID: 26108110
Asia Pac J Ophthalmol (Phila). 2013 May-Jun;2(3):173-6. doi: 10.1097/APO.0b013e318293c772.

The objective of this study was to review the available literature on the drugs causing ocular hypertension and glaucoma. Electronic literature search was carried out using the Web sites www.pubmed.gov and www.google.com published through the year 2011. The search...

Cite
Badhu BP, Bhattarai B, Sangraula HP. Drug-Induced Ocular Hypertension and Angle-Closure Glaucoma. Asia Pac J Ophthalmol (Phila). 2013;2(3):173-6doi: 10.1097/APO.0b013e318293c772.
Badhu, B. P., Bhattarai, B., & Sangraula, H. P. (2013). Drug-Induced Ocular Hypertension and Angle-Closure Glaucoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2(3), 173-6. https://doi.org/10.1097/APO.0b013e318293c772
Badhu, Badri P, et al. "Drug-Induced Ocular Hypertension and Angle-Closure Glaucoma." Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) vol. 2,3 (2013): 173-6. doi: https://doi.org/10.1097/APO.0b013e318293c772
Badhu BP, Bhattarai B, Sangraula HP. Drug-Induced Ocular Hypertension and Angle-Closure Glaucoma. Asia Pac J Ophthalmol (Phila). 2013 May-Jun;2(3):173-6. doi: 10.1097/APO.0b013e318293c772. PMID: 26108110.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries